金城医药：11月4日召开董事会会议

Group 1 - The core point of the article is that Jincheng Pharmaceutical announced the convening of its 18th board meeting on November 4, 2025, to discuss the transfer of drug production technology and related rights [1] - For the year 2024, Jincheng Pharmaceutical's revenue composition is entirely from the pharmaceutical manufacturing industry, accounting for 100.0% [1] - As of the report date, Jincheng Pharmaceutical has a market capitalization of 6.7 billion yuan [1]